Dr. Mesa on Ruxolitinib in Chronic Myeloid Leukemia
1 Visninger
• 07/08/23
0
0
Indlejre
administrator
Abonnenter
Ruben A. Mesa, MD, Professor of Medicine, Division of Hematology & Medical Oncology, Mayo Clinic, discusses the mechanism of action of ruxolitinib in chronic myeloid leukemia.
More on hematologic malignancies: http://www.onclive.com/special....ty/hematologic-cance
Vis mere
Facebook kommentarer
SORT BY-
Topkommentarer
-
Seneste kommentarer